Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

NCT07536789 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepato Cellular Carcinoma (HCC)

Interventions

DRUG: MRG003

Sponsor

Fudan University